Back to mobile site

Anteris Technologies Global (AVR) Reiterated at Overweight by Cantor Fitzgerald on Clinical Case for DurAVR

October 14, 2026 7:21 AM EDT Send to a Friend
Cantor Fitzgerald analyst Gabie Ingoglia reiterated an Overweight rating and $15.00 price target on Anteris Technologies Global (NASDAQ: AVR).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login